Change in rates of prenatal tests for chromosomal abnormality over a 12-year period in women of advanced maternal age.
10.5468/ogs.2018.61.4.453
- Author:
Soo Min KIM
1
;
Hyun Hee KIM
;
You Jung HAN
;
June Seek CHOI
;
Hyun Mee RYU
;
Seongwoo YANG
;
Min Hyoung KIM
Author Information
1. Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea. obdrmhk@naver.com
- Publication Type:Original Article
- Keywords:
Noninvasive prenatal testing;
Prenatal diagnosis;
Maternal age
- MeSH:
Amniocentesis;
Aneuploidy;
Chorionic Villi Sampling;
Chromosome Aberrations*;
Diagnostic Tests, Routine;
Female;
Humans;
Mass Screening;
Maternal Age*;
Pregnancy;
Pregnancy, High-Risk;
Pregnant Women;
Prenatal Diagnosis;
Retrospective Studies
- From:Obstetrics & Gynecology Science
2018;61(4):453-460
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: In 2007, the American College of Obstetricians and Gynecologists (ACOG) recommended that all pregnant women be offered screening or diagnostic tests for chromosomal abnormalities regardless of their age. Noninvasive prenatal testing (NIPT) for common chromosomal aneuploidies was introduced as a screening test in case of high-risk pregnancies. We assessed the rates of prenatal tests in women aged 35 years and older. METHODS: A retrospective study was conducted to compare the rates of amniocentesis, chorionic villus sampling (CVS), serum screening, and NIPT from January 2005 through March 2017 in women aged 35 years and older. We divided the initial 12 months after NIPT introduction into 4-month intervals, beginning in April 2016 through March 2017. RESULTS: The rates of amniocentesis were 56% before the ACOG statement, 38% between the ACOG statement and NIPT introduction, and 10% after NIPT introduction (P=0.001). The rates of CVS during the same periods were 0.5%, 2.1%, and 4.3% (P=0.016), respectively. The rates of serum screening were 44.2%, 61.3%, and 55.1% (P=0.049), respectively. During the 3 quarters after NIPT introduction, the rates of amniocentesis were 16.2%, 12.3%, and 7.3% (P=0.002), respectively; the rates of serum screening were 62%, 54%, and 46% (P=0.03), respectively; and the rates of NIPT were 19.9%, 30.3%, and 39.5% (P=0.007), respectively. The rates of CVS over the same periods were not significantly different. CONCLUSION: The ACOG statement and NIPT introduction significantly decreased the rate of amniocentesis in women of advanced maternal age. NIPT also reduced the rate of serum screening.
